Skip to main content
Top
Published in: Supportive Care in Cancer 4/2007

01-04-2007 | Editorial

Health-related quality of life and predicting survival in cancer: not a simple matter

Author: David Osoba

Published in: Supportive Care in Cancer | Issue 4/2007

Login to get access

Excerpt

The wish to know what the future holds must be as old as the development of self-consciousness in mankind. When we are faced with uncertainties in life, particularly as related to an illness, we wish to know how to predict the course of our illness and its eventual outcome. Although we will generally turn to our physicians or other health care professionals for reassurance and a prognosis, it seems that self-rating our health also provides meaningful predictions of mortality and length of survival. Numerous studies have been published on the value of self-rated health (SRH) as a predictor of mortality after discounting other health status indicators and relevant covariates known to predict mortality [18, 20]. In the general population, self-rated global health is a strong predictor of survival and is associated with socioeconomic status and educational level, whereas gender and race/ethnicity appear to act separately [15]. However, there are several controversies. For example, the role of depression is not clear; it apparently was predictive in some studies and not in others [13, 17, 22]. In a study of 1,355 Israeli men and women, SRH appeared to be predictive of mortality in the short-term (within 4 years of death), but not in the longer term, and the association was stronger in an older age group (ages 85–94) than in younger people [1]. The effect of gender is controversial, with some studies claiming that the association is stronger in men than women [19] and others that it is the opposite [1]. In another study, the effect of gender apparently disappeared by late adulthood [21]. These examples illustrate the complexity of studying the association of SRH and mortality; many factors must be accounted for in the analyses. Nevertheless, the association between SRH and mortality seems to be true not only for the general population but also for many diseases, e.g., diabetes, infectious and respiratory diseases, heart disease, stroke, and cancer [2]. …
Literature
1.
go back to reference Benyamini Y, Blumstein T, Lusky A, Modan B (2003) Gender differences in the self-rated health-mortality association: is it poor self-rated health that predicts mortality or excellent self-rated health that predicts survival? Gerontologist 43:396–405PubMed Benyamini Y, Blumstein T, Lusky A, Modan B (2003) Gender differences in the self-rated health-mortality association: is it poor self-rated health that predicts mortality or excellent self-rated health that predicts survival? Gerontologist 43:396–405PubMed
2.
go back to reference Benjamins MR, Hummer RA, Eberstein IW, Nam CB (2004) Self-reported health and adult mortality risk: an analysis of cause-specific mortality. Soc Sci Med 59:1297–1306PubMedCrossRef Benjamins MR, Hummer RA, Eberstein IW, Nam CB (2004) Self-reported health and adult mortality risk: an analysis of cause-specific mortality. Soc Sci Med 59:1297–1306PubMedCrossRef
3.
go back to reference Coates A, Gebski V, Signorini D et al (1992) Prognostic value of quality-of-life scores during chemotherapy for advanced breast cancer. Australian New Zealand Breast Cancer Trials Group. J Clin Oncol 10:1833–1838PubMed Coates A, Gebski V, Signorini D et al (1992) Prognostic value of quality-of-life scores during chemotherapy for advanced breast cancer. Australian New Zealand Breast Cancer Trials Group. J Clin Oncol 10:1833–1838PubMed
4.
go back to reference Coates AS, Hurny C, Peterson HF et al (2000) Quality-of-life scores predict outcomes in metastatic but not early breast cancer. International Breast Cancer Study Group. J Clin Oncol 18:3768–3774PubMed Coates AS, Hurny C, Peterson HF et al (2000) Quality-of-life scores predict outcomes in metastatic but not early breast cancer. International Breast Cancer Study Group. J Clin Oncol 18:3768–3774PubMed
5.
go back to reference Coates AS, Thomson D, McLeod GR et al (1993) Prognostic value of quality of life scores in a trial of chemotherapy with or without interferon in patients with metastatic melanoma. Eur J Cancer 29A:1731–1734PubMedCrossRef Coates AS, Thomson D, McLeod GR et al (1993) Prognostic value of quality of life scores in a trial of chemotherapy with or without interferon in patients with metastatic melanoma. Eur J Cancer 29A:1731–1734PubMedCrossRef
6.
go back to reference Coates A, Porszolt F, Osoba D (1997) Quality of life in oncology practice: prognostic value of EORTC QLQ-C30 scores in patients with advanced malignancy. Eur J Cancer 33:1025–1030PubMedCrossRef Coates A, Porszolt F, Osoba D (1997) Quality of life in oncology practice: prognostic value of EORTC QLQ-C30 scores in patients with advanced malignancy. Eur J Cancer 33:1025–1030PubMedCrossRef
7.
go back to reference Colette L, van Andel G, Bottomley A et al (2004) Is baseline quality of life a useful tool for predicting survival with hormone-refractory prostate cancer? A pooled analysis of three studies of the European Organisation for Research and Treatment of Cancer Genitourinary Group. J Clin Oncol 22:3877–3885CrossRef Colette L, van Andel G, Bottomley A et al (2004) Is baseline quality of life a useful tool for predicting survival with hormone-refractory prostate cancer? A pooled analysis of three studies of the European Organisation for Research and Treatment of Cancer Genitourinary Group. J Clin Oncol 22:3877–3885CrossRef
8.
go back to reference Dancey J, Zee B, Osoba D et al (1997) Quality of life scores: an independent prognostic variable in a general population of cancer patients receiving chemotherapy. The National Cancer Institute of Canada Clinical Trials Group. Qual Life Res 6:151–158PubMedCrossRef Dancey J, Zee B, Osoba D et al (1997) Quality of life scores: an independent prognostic variable in a general population of cancer patients receiving chemotherapy. The National Cancer Institute of Canada Clinical Trials Group. Qual Life Res 6:151–158PubMedCrossRef
9.
go back to reference Dharma-Wardene M, Au HJ, Hanson J et al (2004) Baseline FACT-G score as a predictor of survival for advanced lung cancer. Qual Life Res 13:1209–11216PubMedCrossRef Dharma-Wardene M, Au HJ, Hanson J et al (2004) Baseline FACT-G score as a predictor of survival for advanced lung cancer. Qual Life Res 13:1209–11216PubMedCrossRef
10.
go back to reference Efficace F, Bignazoli L, Piccart M et al (2004) Baseline health-related quality- of-life data as prognostic factors in a phase III multicentre study of women with metastatic breast cancer. Eur J Cancer 40:1021–1030PubMedCrossRef Efficace F, Bignazoli L, Piccart M et al (2004) Baseline health-related quality- of-life data as prognostic factors in a phase III multicentre study of women with metastatic breast cancer. Eur J Cancer 40:1021–1030PubMedCrossRef
11.
go back to reference Efficace F, Bottomley A, Smit EF et al (2006) Is a patient’s self-reported health-related quality of life a prognostic factor for survival in non-small-cell lung cancer patients? A multivariate analysis of prognostic factors in EORTC study 08975. Ann Oncol 17:1698–1704 (Sep 28)PubMedCrossRef Efficace F, Bottomley A, Smit EF et al (2006) Is a patient’s self-reported health-related quality of life a prognostic factor for survival in non-small-cell lung cancer patients? A multivariate analysis of prognostic factors in EORTC study 08975. Ann Oncol 17:1698–1704 (Sep 28)PubMedCrossRef
12.
go back to reference Efficace F, Therasse P, Piccart MJ et al (2004) Health-related quality of life parameters as prognostic factors in a nonmetastatic breast cancer population: an international multicenter study. J Clin Oncol 22:3381–3388PubMedCrossRef Efficace F, Therasse P, Piccart MJ et al (2004) Health-related quality of life parameters as prognostic factors in a nonmetastatic breast cancer population: an international multicenter study. J Clin Oncol 22:3381–3388PubMedCrossRef
13.
go back to reference Everson-Rose SA, House JS, Mero RP (2004) Depressive symptoms and mortality risk in a national sample: confounding effects of health status. Psychosom Med 66:823–830PubMedCrossRef Everson-Rose SA, House JS, Mero RP (2004) Depressive symptoms and mortality risk in a national sample: confounding effects of health status. Psychosom Med 66:823–830PubMedCrossRef
14.
go back to reference Ferrans CE, Powers MJ (1985) Quality of Life Index: development and psychometric properties. Adv Nurs Science 8:15–21 Ferrans CE, Powers MJ (1985) Quality of Life Index: development and psychometric properties. Adv Nurs Science 8:15–21
15.
go back to reference Franks P, Gold MR, Fiscella K (2003) Sociodemographics, self-rated health and mortality in the US. Soc Sci Med 56:2505–2514PubMedCrossRef Franks P, Gold MR, Fiscella K (2003) Sociodemographics, self-rated health and mortality in the US. Soc Sci Med 56:2505–2514PubMedCrossRef
16.
go back to reference Goodwin PJ, Ennis M, Bordeleau LJ et al (2004) Health-related quality of life and psychosocial status in breast cancer prognosis: analysis of multiple variables. J Clin Oncol 22:4184–4192PubMedCrossRef Goodwin PJ, Ennis M, Bordeleau LJ et al (2004) Health-related quality of life and psychosocial status in breast cancer prognosis: analysis of multiple variables. J Clin Oncol 22:4184–4192PubMedCrossRef
17.
go back to reference Han B (2002) Depressive symptoms and self-rated health in community-dwelling older adults: a longitudinal study. J Am Geriatr Soc 50:1549–1556PubMedCrossRef Han B (2002) Depressive symptoms and self-rated health in community-dwelling older adults: a longitudinal study. J Am Geriatr Soc 50:1549–1556PubMedCrossRef
18.
go back to reference Idler EL, Benyamini Y (1997) Self-rated health and mortality: a review of twenty-seven community studies. J Health Soc Behav 38:21–37PubMedCrossRef Idler EL, Benyamini Y (1997) Self-rated health and mortality: a review of twenty-seven community studies. J Health Soc Behav 38:21–37PubMedCrossRef
19.
go back to reference Idler EL, Russell LB, Davis D (2000) Survival, functional limitations, and self-rated health in the NHANES I Epidemiologic Follow-up Study, 1992. First National Health and Nutrition Survey. Am J Epidemiol 152:874–883PubMedCrossRef Idler EL, Russell LB, Davis D (2000) Survival, functional limitations, and self-rated health in the NHANES I Epidemiologic Follow-up Study, 1992. First National Health and Nutrition Survey. Am J Epidemiol 152:874–883PubMedCrossRef
21.
go back to reference McCullough ME, Laurenceau JP (2004) Gender and the natural history of self-rated health: a 59-year longitudinal study. Health Psychol 23:651–655PubMedCrossRef McCullough ME, Laurenceau JP (2004) Gender and the natural history of self-rated health: a 59-year longitudinal study. Health Psychol 23:651–655PubMedCrossRef
22.
go back to reference Schulz R, Beach SR, Ives DG et al (2000) Association between depression and mortality in older adults: the Cardiovascular Health Study. Arch Intern Med 160:1761–1768PubMedCrossRef Schulz R, Beach SR, Ives DG et al (2000) Association between depression and mortality in older adults: the Cardiovascular Health Study. Arch Intern Med 160:1761–1768PubMedCrossRef
23.
go back to reference Shadbolt B, Barresi J, Craft P (2002) Self-rated health as a predictor of survival among patients with advanced cancer. J Clin Oncol 20:2514–2519PubMedCrossRef Shadbolt B, Barresi J, Craft P (2002) Self-rated health as a predictor of survival among patients with advanced cancer. J Clin Oncol 20:2514–2519PubMedCrossRef
24.
go back to reference Vigano A, Donaldson N, Higginson IJ et al (2004) Quality of life and survival prediction in terminal cancer patients: a multicenter study. Cancer 101:1090–1098PubMedCrossRef Vigano A, Donaldson N, Higginson IJ et al (2004) Quality of life and survival prediction in terminal cancer patients: a multicenter study. Cancer 101:1090–1098PubMedCrossRef
Metadata
Title
Health-related quality of life and predicting survival in cancer: not a simple matter
Author
David Osoba
Publication date
01-04-2007
Publisher
Springer-Verlag
Published in
Supportive Care in Cancer / Issue 4/2007
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-006-0187-6

Other articles of this Issue 4/2007

Supportive Care in Cancer 4/2007 Go to the issue

Forthcoming Meetings

Forthcoming Meetings

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine